Erratum (DOI:10.1016/j.metabol.2006.06.017);Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women

Metabolism: Clinical and Experimental

Volumn 55, Issue 11, 2006, Pages 1473-1480

  Weinberg, Melissa E ^a   Manson, JoAnn E ^a,b   Buring, Julie E ^a,b,c   Cook, Nancy R ^a   Seely, Ellen W ^a   Ridker, Paul M ^a   Rexrode, Kathryn M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

EID: 33749552414     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.003     Document Type: Erratum

References (43)

1. Haffner S.M., Valdez R.A., Hazuda H.P., et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (1992) 715-722
2. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Trevisan M., Liu J., Bahsas F.B., et al. Syndrome X and mortality: a population-based study. Am J Epidemiol 148 (1998) 958-966
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2003) 2486-2497
5. Talbott E., Guzick D., Clerici A., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15 (1995) 821-826
6. Hopkinson Z., Sattar N., Fleming R., et al. Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. BMJ 317 (1998) 329-332
7. Longcope C., Herbert P.N., McKinlay S.M., et al. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women. J Clin Endocrinol Metab 71 (1990) 67-72
8. Preziosi P., Barrett-Connor E., Papoz L., et al. Interrelation between plasma sex hormone binding globulin and plasma insulin in healthy adult women: the Telecom Study. J Clin Endocrinol Metab 76 (1993) 283-287
9. Phillips G.B., Jing T.-Y., and Laragh J.H. Serum sex hormone levels in postmenopausal women with hypertension. J Hum Hypertens 11 (1997) 523-526
10. Haffner S.M., Newcomb P.A., Marcus P.M., et al. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 142 (1995) 925-934
11. Kalish G.M., Barrett-Connor E., Laughlin G.A., et al. Association of endogenous sex hormones and insulin resistance among postmenopausal women: Results from the Postmenopausal Estrogen/Intervention trial. J Clin Endocrinol Metab 88 (2003) 1646-1652
12. Oh J., Barrett-Connor E., Wedick N.M., et al. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 25 (2002) 55-60
13. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., et al. Sex-hormone binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111 (2005) 1242-1249
14. Kuller L.H., Gutai J.P., Meilahn E., et al. Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women. Arteriosclerosis 10 (1990) 1058-1066
15. Shelley J.M., Green A., Smith A.M.A., et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol 8 (1998) 39-45
16. Harrison-Bernard L.M., and Raij L. Postmenopausal hypertension. Curr Hypertens Rep 2 (2000) 202-207
17. Korhonen S., Hippelainen M., Vanhala M., et al. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril 79 (2003) 1327-1334
18. Golden S.H., Ding J., Szklo M., et al. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women. Am J Epidemiol 160 (2004) 540-548
19. Hajamor S., Després J., Couillard C., et al. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metab 52 (2003) 724-730
20. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
21. Rexrode K.M., Lee I.M., Cook N.R., et al. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 9 (2000) 19-27
22. Rexrode K.M., Manson J.E., Lee I., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 108 (2003) 1688-1693
23. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 27 (1990) 532-541
24. Bachmann G., Bancroft J., Braunstein G., et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77 (2002) 660-665
25. Ridker P.M., Buring J.E., Cook N.R., et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
26. Willett W.C., Stampfer M.J., Bain C., et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117 (1983) 651-658
27. Klag M.J., He J., and Mead L.A. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol 3 (1993) 442-447
28. Song Y., Manson J.E., and Buring J.E. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the Women's Health Study. Diabetes Care 27 (2004) 2108-2115
29. Carr M.C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88 (2003) 2404-2411
30. Longcope C. Hormone dynamics at the menopause. Ann NY Acad Sci 592 (1990) 21-30
31. Liu Y., Ding J., Bush T.L., et al. Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol 154 (2001) 489-494
32. Nestler J.E. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance. [editorial]. J Clin Endocrinol Metab 76 (1993) 273-274
33. Goodman-Gruen D., and Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women: the Rancho Bernardo study. Diabetes Care 20 (1997) 645-649
34. Hautanen A. Synthesis and regulation of sex-hormone binding globulin in obesity. Int J Obes 24 (2000) S64-S70
35. Haffner S.M., Katz M.S., and Dunn J.F. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 15 (1991) 471-478
36. Tchernof A., Toth M.J., and Poehlman E.T. Sex hormone binding globulin levels in middle-aged premenopausal women Associations with visceral obesity and metabolic profile. Diabetes Care 22 (1999) 1875-1881
37. Pugeat M., Moulin P., Cousin P., et al. Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J Steroid Biochem Mol Biol 53 (1995) 567-572
38. Hankinson S.E., Manson J.E., Spiegelman D., et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 4 (1995) 649-654
39. Taieb J., Mathian B., Millot F., et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49 (2003) 1381-1395
40. Wang C., Catlin D.H., Demers L.M., et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89 (2004) 534-543
41. Miller K.M., Rosner W., Lee H., et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89 (2004) 525-533
42. Glueck C.J., Papanna R., Wang P., et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52 (2003) 908-915
43. Vrbikova J., Cifkova R., Jirkovska A., et al. Cardiovascular risk factors in young Czech females with polycystic ovarian syndrome. Hum Reprod 18 (2003) 980-984